A Study To Evaluate Methods To Evaluate Back Pain

• Status: Completed
• Trial end date: 2010-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The study is designed to assess methods used in clinical research.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
• Treatments: Analgesics

Criteria

Inclusion Criteria:

• Lower back pain

• Male or female in generally good health, from 18 to 55 years of age (inclusive)

Exclusion Criteria:

• Pregnant or lactating

• Subject has evidence or history of radiculopathy, i.e. sciatica extending below the knee (numbness, tingling, or shooting pain), or other neurologic deficits (abnormal straight leg raise test, patellar reflexes, and/or bowel and bladder function);

• Subject has a history of previous back surgery;

• Subject has back pain resulting from traumatic injury involving physical evidence of bruising, swelling, or inflammation to the abdomen or low back area which occurred less than 48 hours prior to enrollment

• Has taken an investigational drug within the past 30 days prior to entering the study, or currently enrolled in another investigational study

• Is a member or relative of the study site staff, CRO or Sponsor organization directly involved with the study or had a household member or relative participate concurrently or previously in this study

• Has previously been enrolled in this study